Answers are grounded in this paper and cite their sources.
Although clinical trials address questions regarding drug safety for most segments of the population, pregnant women constitute one special group that is "orphaned" with respect to this issue. The lack of adequate pregnancy safety information for the vast majority of medications, combined with a need to make appropriate treatment decisions and to communicate risk information to a potentially vulnerable population, are some of the most challenging and critical women's health issues.
No takes yet. Share an insight, caveat, or question.
Chambers et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: